Acacia Res-Acacia (ACTG) 4.43 $ACTG ACTG: Insiders vs.

New Post Public Reply Private Reply Replies (0) Message Board

Jul 10, 2016 at 2:06 PM

Acacia Res-Acacia (ACTG) 4.43 $ACTG

ACTG: Insiders vs. Shorts
MarketNewsVideo.com - Tue Jun 28, 1:18PM CDT
The most recent short interest data was recently released for the 03/31/2016 settlement date, and Acacia Research Corp is one of the most shorted stocks of the Russell 3000, based on 8.08 "days to cover" versus the median component at 6.29. There...
ACTG: 4.43 (+0.11)

Acacia Subsidiary Signs Settlement and Patent License Agreement with American Gem Society and American Gem Society Laboratories, LLC
BusinessWire - Mon Jun 20, 5:00AM CDT
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Diamond Grading Technologies, LLC. subsidiary has signed a settlement and patent license agreement with American Gem Society and American Gem Society Laboratories, LLC. The agreement resolves litigation that was pending in the United States District Court for the Eastern District of Texas.
ACTG: 4.43 (+0.11)

Acacia Research Has Returned 29.9% Since SmarTrend Recommendation (ACTG)
Comtex SmarTrend(R) - Tue Jun 07, 1:37PM CDT
SmarTrend identified an Uptrend for Acacia Research (NASDAQ:ACTG) on March 21st, 2016 at $3.98. In approximately 3 months, Acacia Research has returned 29.89% as of today's recent price of $5.17.
ACTG: 4.43 (+0.11)

Uptrend Call Working As Acacia Research Stock Rises 31.4% (ACTG)
Comtex SmarTrend(R) - Tue May 31, 12:56AM CDT
SmarTrend identified an Uptrend for Acacia Research (NASDAQ:ACTG) on March 21st, 2016 at $3.98. In approximately 2 months, Acacia Research has returned 31.41% as of today's recent price of $5.23.
ACTG: 4.43 (+0.11)

Acacia Research (ACTG) is in Overbought Territory: What's Next?
Zacks Equity Research - Zacks Investment Research - Fri May 27, 8:17AM CDT
Acacia Research Corporation (ACTG) has moved higher as of late, but there could definitely be trouble on the horizon for this company.
ACTG: 4.43 (+0.11)

Upgrade Alert for Acacia Research (ACTG)
Comtex SmarTrend(R) - Tue May 24, 3:01AM CDT
Acacia Research (NASDAQ:ACTG) was upgraded from Market Perform to Outperform at Northland today. The stock closed yesterday at $5.08 on volume of 613,000 shares, above average daily volume of 505,000. In the past 52 weeks, shares of Acacia Research have traded between a low of $2.82 and a high of $10.86 and closed yesterday at $5.08, which is 80% above that low price. Over the past week, the 200-day moving average (MA) has gone down 1.3% while the 50-day MA has advanced 1.7%.
ACTG: 4.43 (+0.11)

Uptrend Call Working As Acacia Research Stock Rises 26.8% (ACTG)
Comtex SmarTrend(R) - Mon May 23, 1:12PM CDT
SmarTrend identified an Uptrend for Acacia Research (NASDAQ:ACTG) on March 21st, 2016 at $3.98. In approximately 2 months, Acacia Research has returned 26.76% as of today's recent price of $5.05.
ACTG: 4.43 (+0.11)

Acacia Research (ACTG) is Overbought: Is A Drop Coming?
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 8:50AM CDT
Acacia Research Corp (ACTG) has moved higher as of late, but there could definitely be trouble on the horizon for this company
ACTG: 4.43 (+0.11)

Xerox (XRX) Misses on Q1 Earnings, Split Likely in 2016
Supriyo Bose - Zacks Investment Research - Mon Apr 25, 9:39AM CDT
Xerox Corporation (XRX) reported relatively modest first-quarter 2016 results with adjusted earnings (from continuing operations) of 22 cents per share compared with 24 cents in the year-ago quarter.
PFMT: 1.59 (-0.08), ACTG: 4.43 (+0.11), XRX: 9.54 (+0.16), PFSW: 9.41 (+0.15)

Acacia Research reports 1Q loss
Automated Insights - Thu Apr 21, 3:21PM CDT
NEWPORT BEACH, Calif. (AP) _ Acacia Research Corp. (ACTG) on Thursday reported a loss of $10 million in its first quarter.
ACTG: 4.43 (+0.11)

Acacia Research Reports First Quarter Financial Results
BusinessWire - Thu Apr 21, 3:00PM CDT
Acacia Research Corporation(1) (Nasdaq: ACTG) today reported results for the three months ended March 31, 2016.
ACTG: 4.43 (+0.11)

Domtar Provides Sneak Peek into First-Quarter 2016 Results
Zacks Equity Research - Zacks Investment Research - Mon Apr 18, 1:19PM CDT
Domtar Corporation (UFS), a leading fiber-based technology company, recently provided an update on its first quarter 2016 financial performance.
ACTG: 4.43 (+0.11), UFS: 33.24 (-0.89), FBR: 6.48 (-0.13)

Healthcare Services Q1 Earnings in Line, Dividend Raised
Zacks Equity Research - Zacks Investment Research - Wed Apr 13, 9:00AM CDT
Healthcare Services Group, Inc. (HCSG) reported first-quarter 2016 net income of 26 cents per share, in line with the Zacks Consensus Estimate.
VEC: 29.85 (+1.16), ACTG: 4.43 (+0.11), PRGX: 5.04 (+0.04), HCSG: 41.02 (+0.56)

What Falling Estimates & Price Mean for Everi Holdings (EVRI)
Zacks Equity Research - Zacks Investment Research - Wed Apr 13, 8:07AM CDT
Everi Holdings has witnessed a significant price decline in the past four weeks and negative estimate revisions, making it time for investors to sell it off
ACTG: 4.43 (+0.11), EVRI: 1.43 (+0.17)

Ocean Tomo Announces Completion of over $650 Million in Intellectual Property Transaction Volume
PRWeb - Tue Apr 12, 3:46PM CDT
Ocean Tomo, LLC, the intellectual capital merchant banc™ firm, announced today updated performance of the Ocean Tomo Transactions Business Unit. Ocean Tomo has served as a trusted advisor to both large and small operating company patent owners, successfully closing a number of transactions with cumulative transaction value in excess of $650 million.
ACTG: 4.43 (+0.11)

Acacia Research Names Frank E. Walsh, III to Its Board of Directors
BusinessWire - Thu Apr 07, 5:00AM CDT
Acacia Research Corporation (NASDAQ: ACTG) announced today that Frank E. Walsh, III has joined its Board of Directors.
ACTG: 4.43 (+0.11), FCCY: 11.83 (-0.16)

US Ecology (ECOL) to Divest Non-Core Asset USE Augusta
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 2:30PM CDT
US Ecology, Inc. (ECOL), a renowned North American firm, recently announced the strategic sale of its non-hazardous solid and liquid waste processing unit, USE Augusta
CBZ: 10.56 (+0.12), ECOL: 46.92 (+1.39), ACTG: 4.43 (+0.11), WM: 67.61 (+0.32)

Acacia Research to Release First Quarter Financial Results and Host Conference Call
BusinessWire - Wed Apr 06, 5:00AM CDT
Acacia Research Corporation (NASDAQ: ACTG) announced today it will release its first quarter financial results on Thursday, April 21, 2016. Results will be released at 4:00 PM (EDT) / 1:00 PM (PDT).
ACTG: 4.43 (+0.11)

The Zacks Analyst Blog Highlights: Acacia Research, CalAmp, Renewable Energy Group and Sucampo Pharmaceuticals
Zacks Equity Research - Zacks Investment Research - Fri Apr 01, 8:30AM CDT
The Zacks Analyst Blog Highlights: Acacia Research, CalAmp, Renewable Energy Group and Sucampo Pharmaceuticals
REGI: 8.51 (+0.15), ACTG: 4.43 (+0.11), CAMP: 14.25 (+0.58), SCMP: 11.49 (+0.10)

Acacia Subsidiary Signs Patent License Agreement with Ericsson Inc. and Telefonaktiebolaget LM Ericsson
BusinessWire - Fri Apr 01, 5:00AM CDT
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Adaptix, Inc. subsidiary has signed a patent license agreement with Ericsson, Inc. and Telefonaktiebolaget LM Ericsson. The agreement resolves litigation that was pending in the United States District Court for the Eastern District of Texas.
ACTG: 4.43 (+0.11)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Stands Tall with iPhone 18 Pro Cases

By Riley Hayes Updated Oct 24, 2026 Category News Views 239

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Darden Faces Class Action Over Reimbursement Failures

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

CapCut's AI Tools Reshape Video Content Creation

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Master Sommeliers and Italian Producers Clash on Wine Lists

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...